Phase II study of oxaliplatin in combination with navelbine [vinorelbine] for the second-Line treatment of advanced and metastatic non-small cell lung cancer.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Oxaliplatin (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ELVIS-II
- 25 Jul 2007 Altered status to match nct record (had planning instead of inititated for "not yet recruiting").
- 22 Sep 2006 New trial record.